Reported about 19 hours ago
As political changes create uncertainty in the healthcare sector, several blue-chip dividend-paying stocks have fallen to attractive valuations. Investors should consider AbbVie, offering a 3.7% yield, Pfizer with a 6.7% yield, and Johnson & Johnson, which has a 3.2% yield. These companies, while facing challenges, have solid fundamentals and growth prospects, making them compelling options for long-term investors looking for quality dividend stocks.
Source: YAHOO